Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 101 to 110 of 302

TitleReference numberPublishedLast updated
Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancerTA724
Abiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancerTA721
Immunoscore for predicting risk of colon cancer relapseMIB269
Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA716
trublood-prostate for triaging and diagnosing people with prostate cancer symptomsMIB268
Enzalutamide for treating hormone-sensitive metastatic prostate cancerTA712
Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapyTA713
Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA709
Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancerTA707
Atezolizumab monotherapy for untreated advanced non-small-cell lung cancerTA705

Results per page

  1. 10
  2. 25
  3. 50
  4. All